Letter to the Editor: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment

被引：0
|
作者：
Liu, Qingran [1 ]
Li, Jinpeng [2 ]
Chen, Hua [2 ]
Song, Jinlong [2 ]
机构：
[1] Shandong First Med Univ, Binzhou Peoples Hosp, Dept Intervent Med, Binzhou, Shandong, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Intervent Therapy 1, Jinan 250117, Shandong, Peoples R China
来源：
HEPATOLOGY | 2025年 / 81卷 / 03期
关键词：
D O I：
10.1097/HEP.0000000000001215
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E101 / E102
页数：2
相关论文
共 50 条
  • [31] Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
    Rossari, Federico
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Yoo, Changhoon
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Masi, Gianluca
    Bergamo, Francesca
    Amadeo, Elisabeth
    Vitiello, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Iavarone, Massimo
    Cabibbo, Giuseppe
    Montes, Margarida
    Foschi, Francesco Giuseppe
    Vivaldi, Caterina
    Solda, Caterina
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Hiraoka, Atsushi
    LIVER CANCER, 2024, 13 (05) : 522 - 536
  • [32] Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
    Chon, Young Eun
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kang, Beodeul
    Ha, Yeonjung
    Kim, Do Young
    Hwang, Seong Gyu
    Chon, Hong Jae
    Kim, Beom Kyung
    CANCER MEDICINE, 2023, 12 (03): : 2731 - 2738
  • [33] The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Shimose, Shigeo
    Iwamoto, Hideki
    Shirono, Tomotake
    Tanaka, Masatoshi
    Niizeki, Takashi
    Kajiwara, Masahiko
    Itano, Satoshi
    Yano, Yoichi
    Matsugaki, Satoru
    Moriyama, Etsuko
    Noda, Yu
    Nakano, Masahito
    Kuromatsu, Ryoko
    Koga, Hironori
    Kawaguchi, Takumi
    CANCER MEDICINE, 2023, 12 (11): : 12325 - 12335
  • [34] Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab
    Campani, Claudia
    Vallot, Ariane
    Ghannouchi, Haroun
    Allaire, Manon
    Evain, Manon
    Sultanik, Philippe
    Sidali, Sabrina
    Blaise, Lorraine
    Thabut, Dominique
    Nahon, Pierre
    Seror, Olivier
    Ganne-Carrie, Nathalie
    Nault, Jean-Charles
    Wagner, Mathilde
    Sutter, Olivier
    HEPATOLOGY, 2024, 79 (01) : 49 - 60
  • [35] Two cases of hepatocellular carcinoma successfully treated by carbon ion radiotherapy after atezolizumab plus bevacizumab treatment
    Takakusagi, Satoshi
    Tanaka, Hinako
    Naganuma, Atsushi
    Kakizaki, Satoru
    Shibuya, Kei
    Ohno, Tatsuya
    Takagi, Hitoshi
    Uraoka, Toshio
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (03) : 407 - 415
  • [36] Two cases of hepatocellular carcinoma successfully treated by carbon ion radiotherapy after atezolizumab plus bevacizumab treatment
    Satoshi Takakusagi
    Hinako Tanaka
    Atsushi Naganuma
    Satoru Kakizaki
    Kei Shibuya
    Tatsuya Ohno
    Hitoshi Takagi
    Toshio Uraoka
    Clinical Journal of Gastroenterology, 2023, 16 : 407 - 415
  • [37] Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series
    Kang, Wendi
    Fu, Hongjiang
    Luo, Yingen
    Noreika, Danielle M.
    Cong, Tianhao
    Li, Hang
    Yang, Zhengqiang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 780 - 787
  • [38] The clinical impact of urinary protein creatinine ratio and AFP at six weeks in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
    Tsuchiya, K.
    Yamada, M.
    Yasui, Y.
    Yamazaki, Y.
    Uchihara, N.
    Suzuki, K.
    Tanaka, Y.
    Miyamoto, H.
    Keitoku, T.
    Okada, R.
    Higuchi, M.
    Takaura, K.
    Tanaka, S.
    Maeyashiki, C.
    Tamaki, N.
    Nakanishi, H.
    Kurosaki, M.
    Izumi, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S604 - S605
  • [39] Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices
    Fujimasa Tada
    Atsushi Hiraoka
    Toshifumi Tada
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Hironori Ochi
    Hidenori Toyoda
    Chikara Ogawa
    Takashi Nishimura
    Takeshi Hatanaka
    Satoru Kakizaki
    Noritomo Shimada
    Kazuhito Kawata
    Atsushi Naganuma
    Hisashi Kosaka
    Tomomitsu Matono
    Hidekatsu Kuroda
    Yutaka Yata
    Hideko Ohama
    Kazuhiro Nouso
    Asahiro Morishita
    Akemi Tsutsui
    Takuya Nagano
    Norio Itokawa
    Tomomi Okubo
    Taeang Arai
    Keisuke Yokohama
    Hiroki Nishikawa
    Michitaka Imai
    Yohei Koizumi
    Shinichiro Nakamura
    Hiroko Iijima
    Masaki Kaibori
    Yoichi Hiasa
    Takashi Kumada
    Journal of Gastroenterology, 2023, 58 : 1134 - 1143
  • [40] FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
    Casak, Sandra J.
    Donoghue, Martha
    Fashoyin-Aje, Lola
    Jiang, Xiaoping
    Rodriguez, Lisa
    Shen, Yuan-Li
    Xu, Yuan
    Jiang, Xiling
    Liu, Jiang
    Zhao, Hong
    Pierce, William F.
    Mehta, Shubhangi
    Goldberg, Kirsten B.
    Theoret, Marc R.
    Kluetz, Paul G.
    Pazdur, Richard
    Lemery, Steven J.
    CLINICAL CANCER RESEARCH, 2021, 27 (07) : 1836 - 1841
12345